On Friday, Cellectar Biosciences Inc (NASDAQ: CLRB) opened lower -9.82% from the last session, before settling in for the closing price of $0.29. Price fluctuations for CLRB have ranged from $0.22 to $4.15 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 47.54% at the time writing. With a float of $45.31 million, this company’s outstanding shares have now reached $46.08 million.
The extent of productivity of a business whose workforce counts for 11 workers is very important to gauge. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Cellectar Biosciences Inc (CLRB) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Cellectar Biosciences Inc is 1.67%, while institutional ownership is 11.18%. The most recent insider transaction that took place on Jan 10 ’25, was worth 8,400. In this transaction Chief Operating Officer of this company bought 30,000 shares at a rate of $0.28, taking the stock ownership to the 83,141 shares.
Cellectar Biosciences Inc (CLRB) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.15 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 47.54% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 16.51% during the next five years compared to 40.27% growth over the previous five years of trading.
Cellectar Biosciences Inc (NASDAQ: CLRB) Trading Performance Indicators
Check out the current performance indicators for Cellectar Biosciences Inc (CLRB). In the past quarter, the stock posted a quick ratio of 2.58.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.51, a number that is poised to hit -0.16 in the next quarter and is forecasted to reach -0.70 in one year’s time.
Technical Analysis of Cellectar Biosciences Inc (CLRB)
The latest stats from [Cellectar Biosciences Inc, CLRB] show that its last 5-days average volume of 0.9 million was inferior to 1.66 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 10.92%. Additionally, its Average True Range was 0.03.
During the past 100 days, Cellectar Biosciences Inc’s (CLRB) raw stochastic average was set at 2.04%, which indicates a significant decrease from 18.98% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 88.11% in the past 14 days, which was lower than the 241.26% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.3055, while its 200-day Moving Average is $1.4008. Now, the first resistance to watch is $0.2947. This is followed by the second major resistance level at $0.3249. The third major resistance level sits at $0.3566. If the price goes on to break the first support level at $0.2328, it is likely to go to the next support level at $0.2011. Assuming the price breaks the second support level, the third support level stands at $0.1709.
Cellectar Biosciences Inc (NASDAQ: CLRB) Key Stats
There are currently 46,080K shares outstanding in the company with a market cap of 12.18 million. Presently, the company’s annual sales total 0 K according to its annual income of -44,580 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -7,420 K.
